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Numerous government agencies, medical orga-
nizations, and researchers have stressed the
need for additional epidemiologic research on
multiple chemical sensitivities (MCS) (Ashford
and Miller 1998). In a federal government
publication on MCS , Mitchell (1995) out-
lined the need for epidemiologic research “to
characterize the cases sufficiently for further
work” and “to establish the magnitude of the
problem caused by the MCS phenomenon in
the population.” Additionally, a federal gov-
ernment report indicated that the uncertainties
surrounding the etiology, dynamics, and
symptomatology of MCS could only be
solved by a dramatic increase in research
efforts (Interagency Workgroup on Multiple
Chemical Sensitivity 1998).
This study consists of a two-phase investi-
gation of the prevalence, symptomatology,
and etiology of MCS. The initial phase
focuses on the prevalence of MCS in the met-
ropolitan Atlanta, Georgia, area. The second
phase is a more extensive follow-up question-
ing of the positive respondents from the ﬁrst
phase, which focuses on symptomatology, eti-
ology, and other aspects of hypersensitivity.
MCS Prevalence
MCS is generally acknowledged to be a con-
dition where individuals have an acute hyper-
sensitivity to low levels of chemicals found in
everyday substances such as household clean-
ing agents, pesticides, fresh paint, new carpet-
ing, synthetic building materials, newsprint,
perfume, and numerous other petrochemical-
based products (Davidoff et al. 2000). MCS
can produce a wide range of symptoms, and
individuals with hypersensitivity can
encounter great difﬁculty functioning in nor-
mal working and living environments (Lax
and Henneberger 1995).
Estimates of the number of people who
have MCS vary widely. A National Academy
of Sciences (NAS) report initially speculated
that up to 15% of the American public could
be experiencing a heightened sensitivity to
common chemical products (NAS 1981).
Subsequent research that used a variety of
methodologies, however, produced different
prevalence rates.
Previous prevalence research. Existing
research on the prevalence of MCS tends to
fall into two broad categories based on the
characteristics of the individuals used as sub-
jects. The ﬁrst category includes subjects who
are either self-selected or have common charac-
teristics that place them in speciﬁc subgroups.
Subgroups have consisted of individuals who
either sought treatment at a medical clinic or
had previously indicated that they had a med-
ical condition. Other subgroups have been
based on demographic characteristics such as
age. The second category is a sample composed
of randomly selected individuals from the gen-
eral public. Studies in this category use a prob-
ability-based subject selection process to ensure
that every member of the population had an
equal chance of being included in the study.
Early MCS prevalence studies fall into the
ﬁrst category because they used research sub-
jects who either were self-selected or had spe-
cial characteristics. More recent epidemiologic
research on MCS, however, typically falls into
the second category.
A number of investigations have been
conducted since 1990 that attempted to
assess the prevalence of MCS in the U.S.
population. In an early study, based exclu-
sively on anecdotal evidence from conversa-
tions with medical personnel, Mooser (1987)
suggested that 2–10% of the population suf-
fered disruptive effects because of a hypersen-
sitivity to chemical substances. Additional
studies, however, questioned the validity of
anecdotal evidence and suggested that this
prevalence rate was an underestimate. One of
the first studies to project the prevalence of
MCS from a subgroup used a sample com-
posed of 705 medical clinic patients (Kipen et
al. 1995). Two subsequent studies also used
subjects from specialized subgroups: one sam-
ple group was composed of 809 young adult
college students (Bell et al. 1993) and one
group comprised 160 elderly persons (Bell et
al. 1997), both in Arizona. In these studies
(Bell et al. 1993, 1997), approximately 15%
of the younger sample and more than 37% of
the elderly group reported a hypersensitivity.
In a random telephone survey of 1,027
residents in rural North Carolina, Meggs et
al. (1996) determined that 33% of respon-
dents reported becoming sick after smelling
chemical odors (e.g., perfume, pesticide, fresh
paint, car exhaust, newsprint). Although this
study used a random sample that could be
representative of the general public, the word-
ing of the key questions did not distinguish
between a normal aversion to harsh chemical
odors and a true hypersensitivity to common
substances at low levels.
The California Department of Health
Services (CDHS) conducted the most exten-
sive epidemiologic research on MCS to date
(Kreutzer et al. 1999). The federally funded
CDHS asked experts familiar with MCS to
suggest optimum wording for questions to be
included in a state-conducted medical survey.
The survey, administered in 1998, took sam-
ples from different regions of the state and
included more than 4,000 respondents.
Kreutzer et al. (1999) found that 15.9% of
respondents reported unusual sensitivity to
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the original NAS estimate (NAS 1981). The
CDHS study (Kreutzer et al. 1999) also
included data on sex, educational level, marital
status, and racial/ethnic linkage with MCS.
Earlier anecdotal evidence had suggested that
white women of higher educational status dis-
proportionately reported MCS (Cullen 1992).
The CDHS study (Kreutzer et al. 1999),
however, found a heterogeneous distribution
of MCS that cuts across gender, race, and
educational categories.
First Phase
In the ﬁrst phase of this study—a population-
based prevalence study conducted in 1999–
2000 (Caress and Steinemann. In press), we
investigated the prevalence of a hypersensitivity
to common chemical products and the extent
of the medical diagnosis of MCS in the Atlanta,
Georgia, metropolitan area. This stage of the
study also included a preliminary exploration of
the severity and potential causes (initiations) of
hypersensitivity. Additionally, we examined
lifestyle changes, age of onset, and potential
linkages between MCS and the demographic
variables of sex, age, and educational level.
Methods
The construction of the research design for
this phase required the development of a mea-
surement instrument, selection of a target
population, and determination of sampling
techniques and sample size. In addition, con-
cerns of reliability and operational and exter-
nal validity had to be addressed.
The Interagency Work Group on Multiple
Chemical Sensitivities (1998) concluded that
“questionnaires are one of the most useful tools
in epidemiologic investigations.” The question-
naire used in our study was constructed to
investigate both the medical diagnosis and
symptomatology of MCS, as well as other
facets of chemical hypersensitivity. To ensure
external validity of the questionnaire (the
assumption that the results of this study may
be applicable to other populations), we repli-
cated the exact wording of the key questions
used in the CDHS questionnaire (Kreutzer et
al. 1999). This replication also facilitates an
analytical comparison between our study and
Kreutzer et al.
The process of determining the sample size
to ensure operational validity is contingent on
the degree of random error associated with the
measurement. Consequently, a sufﬁciently large
sample was required. The number of cases nec-
essary to ensure validity is based on the desired
confidence levels and confidence intervals;
therefore, a conﬁdence level of 95% is accept-
able for this type of research. The degree of
accuracy of the ﬁndings (conﬁdence interval) of
3% is normally desirable for epidemiologic
inquiries (O’Sullivan and Rassel 1995).
We used both conﬁdence level and degree
of accuracy in a standard probability formula
to determine the size of the sample. The stan-
dard formula is as follows: 
n2 = proportion2 × (1 – proportion) × z
where the n is the sample size and z is the
z-score (standard score corresponding to the
appropriate conﬁdence level) (O’Sullivan and
Rassel 1995). This formula indicated that for a
study to achieve a conﬁdence level of 95% with
a 3% degree of accuracy, it must have at least
1,067 cases. Therefore, a phone list of 2,000
telephone numbers was generated to ensure a
sufficiently large sample. A total of 1,582
respondents ultimately completed the question-
naire; thus, the sample size of this study
exceeded the size necessary to obtain the desired
conﬁdence level and degree of accuracy. For the
data-gathering procedure in this study, we used
random sampling methods to protect from any
systematic bias in the data. Phone numbers ran-
domly selected (lottery method) from lists gen-
erated by the local phone company were used
to construct the sample. The target population
of the Atlanta, Georgia, metropolitan area was
covered by using telephone numbers from the
770 and 404 area codes.
We increased the reliability of the question-
naire by ensuring that the data demonstrated
stability. The data, therefore, were gathered in
three separate cohorts. We administered the
questionnaire to 496 individuals in the sum-
mer of 1999. We surveyed a second cohort of
322 individuals in fall 1999 and a third cohort
of 764 individuals in the winter and spring of
2000. The winter and spring cohort was larger
because the data-gathering covered a longer
period. The findings of each separate cohort
were examined to identify any signiﬁcant devi-
ation. Because the results of all three cohorts
displayed only minor variation (essentially
equivalent given the 3% conﬁdence interval),
we judged the data to be stable and combined
data from the three cohorts. Thus, all results
in the study are an aggregation of the three
cohorts.
Prior to gathering data, we conducted a
pretest to evaluate the face validity of the ques-
tionnaire (respondents’ belief that the ques-
tions asked them accurately reﬂected what was
being studied). A test group of 253 individuals
was used to evaluate the original questionnaire,
which was lengthier than the ﬁnal version. An
unexpectedly large number of respondents ter-
minated the interview before its completion
because they found the questionnaire too time-
consuming or tiring. The face validity evalua-
tion and a subsequent item analysis provided
the impetus for shortening the questionnaire.
Less-pertinent questions were removed, and
the final version contained 12 health-related
questions and three additional demographic
questions.
The ﬁnal version of the questionnaire ini-
tially inquired if the respondent has ever been
diagnosed with MCS or environmental ill-
ness. A subsequent key question, which used
the same wording as the CDHS, was 
compared to other people, do you consider your-
self unusually sensitive to everyday chemicals like
those in household cleaning products, perfume,
detergents, insect spray and things like that?
Respondents who replied positively to the key
question were asked several additional questions
that investigated symptom severity, origin (ini-
tiation), age of onset, and behavior modiﬁca-
tions. Demographic questions on age, sex, and
educational level were asked of all respondents.
Findings
The aggregated data showed that 12.6%
(n = 199) of the respondents reported an
unusual sensitivity to common chemical sub-
stances (Table 1). An additional 1.4% (n = 22)
were not certain if they had hypersensitivity.
Of the respondents, 3.1% (n = 49) reported
that they had been medically diagnosed as
having either environmental illness or MCS.
Of the individuals who reported that they
were unusually sensitive to common chemicals,
or suspected it, 42.7% (n = 93) could identify
an original cause (initiation) of their hypersen-
sitivity. Of these, the cause of hypersensitivity
was reported to be chemical exposure by
12.4% (n = 27); an exposure to pesticides by
5% (n = 11); other types of exposure by 11.5%
(n = 25); and other causes by 13.8% (n = 30).
Of the respondents who reported sensitivi-
ties, 45.1% (n = 106) received medical treat-
ment (Table 1). A majority of the respondents
(61.5%, n = 142) reported taking some
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Table 1. First-phase data: prevalence of sensitivity and behavior modiﬁcations.a
Yes No Not sure Refuse
Question % (n)%  ( n)%  ( n)%  ( n)
Sensitive to chemicals 12.6 (199) 85.7 (1,351) 1.4 (22) 0.3 (4)
MCS diagnosed 3.1 (49) 95.3 (1,504) 1.6 (25) 0.1 (1)
Received treatmentb 45.1 (106) 47.2 (111) 5.5 (13) 2.1 (5)
Take precautions at homeb 61.5 (142) 30.3 (70) 5.2 (12) 2.6 (6)
Difﬁculty shoppingb 29.9 (64) 65 (139) 5.1 (11) 0 (0)
Lost jobb 13.5 (29) 84.7 (182) 0.5 (1) 1.4 (3)
aUnequal totals result from rounding and/or missing data. bAsked only of subjects who reported a hypersensitivity to
chemicals.precautions at home because of their hyper-
sensitivity. Somewhat less than one-third
(29.9%, n = 64) indicated that their hypersen-
sitivity made it difﬁcult to shop in stores in a
normal manner. Moreover, 13.5% (n = 29) of
the respondents lost their jobs because their
hypersensitivity prevented them from func-
tioning adequately in their workplace. The
number of respondents who lost employment
because of their hypersensitivity represents
approximately 1.8% of the entire sample. We
also asked positive respondents at what age
their symptoms ﬁrst appeared; responses were
as follows: before 20 years of age, 32.4% (n =
70); 21–36 years of age, 35.2% (n = 76);
26–50 years of age, 14.8% (n = 32); and after
50 years of age, 9.7% (n = 21) (Table 2).
The educational level distribution of the
entire sample was evenly spread; 10.1%
(n = 52) had less than a high school education,
24.7% (n = 374) were high school graduates,
25.7% (n = 389) had some college, 31.5%
(n = 477) were college graduates, and 7.9%
(n = 120) had postgraduate education
(Table 3). The sex distribution of the sample
was 59.8% female and 38.8% male (Table 3).
A cross-tabulation with sensitivity and edu-
cation level indicates that positive respondents
were also fairly evenly distributed across all edu-
cation levels, with a minor bias toward higher
educational levels (Table 4). People with a high
school education or less made up 36% (n = 69)
of the total number of positive respondents,
with college graduates and individuals with
postgraduate education making up 33% (n =
64), and people with some college comprising
31% (n = 60) (Table 4). The educational level
distribution of positive respondents, therefore,
is comparable to the education level of the
entire sample. The cross tabulations also indi-
cate a sex distribution slanted somewhat toward
females; respondents who reported an unusual
sensitivity to chemicals were 71.7% female and
28.3% male (Table 4).
Discussion: First-Phase Findings
Although a 12.6% positive response rate
(Kreutzer et al. 1999) is below the level found
in the CDHS study, when we consider a sam-
pling error of 3%, the rates are essentially sta-
tistically equivalent. These findings are
consistent with the NAS estimate (NAS 1981)
that up to 15% of Americans have a hypersen-
sitivity to low levels of common chemicals.
The potential of a sex linkage was suggested in
the earlier clinic-based studies, with the specu-
lation that MCS is primarily a female condi-
tion. The CDHS study (Kreutzer et al. 1999)
found a higher incidence of females in its total
sample reporting a hypersensitivity (16% of
females sampled vs. 6.9% of the males).
Females also comprise 71.7% of the respon-
dents who reported unusual hypersensitivity in
our study. This would initially suggest that
females are disproportionately more likely to
have the symptomatology of MCS than males.
This proportion, however, is less dramatic
when the female bias in the sample is consid-
ered. The total sample in our study was 59.8%
female, which is somewhat higher but statisti-
cally congruent with the female population of
northwestern Georgia, which is 51.3% female.
The CDHS study also had a larger number of
female respondents (59%) than in the general
population of California, but this is also well
within acceptable parameters. The actual per-
centage of males in our study who experienced
MCS, when adjusted for the sample bias, was
approximately one-third, which suggests that
although females report a higher incidence of
hypersensitivity, it affects both sexes.
Early clinic-based studies suggested that a
hypersensitivity is more common in individu-
als with a higher level of education (Cullen et
al. 1992). Critics of this conclusion argue that
highly educated individuals are only more
likely to seek treatment and be diagnosed with
MCS, whereas less-educated people are more
likely to remain undiagnosed. Our study tends
to support the latter observation. The data are
similar to the CDHS results (Kreutzer et al.
1999), which indicate that a hypersensitivity
to chemicals is widely distributed across 
education levels (Table 4), which, as noted in
the CDHS study, suggests that a universal
etiology is probable.
Second Phase
The second phase, conducted in the spring of
2000, consisted of an extensive follow-up
examination of respondents who reported a
hypersensitivity to chemicals in the initial
phase. (Caress et al. 2002). It explored sympto-
matology, etiology, potential triggering agents,
and linkages to other disorders. The second
phase also examined the potential linkage
between the onset of reactions and specific
chemical substances, as well as lifestyle modiﬁ-
cations made by hypersensitive individuals.
Theories of Etiology and Dynamics
Current research suggests that MCS exhibits a
two-step process of initiation (causation) and
triggering (subsequent reactions) (Ashford and
Miller 1998). Hypersensitivity emerges after
initiation, which can result from a massive
exposure to a specific toxic agent (Rea et al.
1978) or a chronic exposure to one or more
toxic substances, even at low levels (Miller et
al. 1997). After initiation, triggering occurs,
which involves reactions to a wider range of
substances.
Theories about the nature of initiation have
been based on one or more of the following sys-
tems: neurologic, immunologic, endocrine, and
psychologic (Interagency Workgroup on
Multiple Chemical Sensitivity 1998). Fiedler et
al. (1992) suggested that neurologic disorders
are connected to MCS, and other studies have
indicated that MCS is associated with immuno-
logic dysfunctions. Some researchers contend,
however, that MCS does not follow the same
pattern as immunologic disorders (Ziem 1992),
which has led other researchers to examine the
connection between MCS and immune dys-
function linked to the neuroendocrine system
(Meggs 1992). It also has been suggested that
inﬂammation of the respiratory tract (Meggs
1995) and disorders such as porphyria are
potential causative factors (Ellefson and Ford
1996). Other researchers have examined the
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Table 2. First-phase data: onset age and etiology.a
Question % (n)
Age of onset of hypersensitivity (years)b
< 20 32.4 (70)
21–35 35.2 (76)
36–50 14.8 (32)
> 50 7.9 (17)
Refuse/don’t know 9.7 (21)
Original cause of hypersensitivityb
Chemical exposure 12.4 (27)
Pesticide exposure 5.0 (11)
Other exposure 11.5 (25)
Other cause 13.8 (30)
Don’t know 57.3 (125)
aUnequal totals result from rounding and/or missing data.
bOnly asked subjects who had or suspected hypersensitivity. 
Table 3. First-phase data: respondent demographics
(entire sample).a
Question % (n)
What is your age?
< 20 years 5.8 (89)
21–35 years 24.3 (373)
36–50 years 33.2 (510)
> 50 years 34.5 (530)
Refuse/don’t know 2.3 (35)
What is your sex?
Male 38.8 (600)
Female 59.8 (926)
No answer 1.4 (22)
What is your educational level?
Did not complete high school 10.1 (152)
High school graduate 24.7 (374)
Some college 25.7 (389)
College graduate 31.5 (477)
Professional/graduate school 7.9 (120)
aUnequal totals result from rounding and/or missing data.
Table 4. Cross-tabulations of first-phase data:
education and sensitivity to chemicals and sex and
sensitivity to chemicals.a
Are you sensitive Yes No
to chemicals? % (n)%  ( n)
Education
Did not complete high school 14 (27) 9 (120)
High school graduate 22 (42) 25 (325)
Some college 31 (60) 25 (321)
College graduate 24 (47) 33 (425)
Graduate/professional school 9 (17) 8 (100)
Sex
Male 28.3 (53) 42.2 (539)
Female 71.7 (142) 57.8 (763)
aRespondents who answered “not sure” or “refuse” were
not included.role of the limbic system (Bell et al. 1995)
and metabolic mechanisms in MCS (Byers et
al. 1988). Examinations of a relationship
between MCS and other conditions such as
systemic lupus, chronic fatigue syndrome,
and fibromyalgia have also been conducted
(Ashford and Miller 1998; Interagency
Workgroup on Multiple Chemical Sensitivity
1998). Additional studies focus on the role of
psychologic factors. These psychologically
based studies speculate that hypersensitivity
to low levels of chemicals may be a somatiza-
tion disorder (Black et al. 1990) or a condi-
tioned response (Siegel and Kreutzer 1997).
Psychogenic theories, however, have been
criticized for methodologic weaknesses, such
as biased patient selection and the lack of
presymptom data (Davidoff and Fogarty 1994).
Miller and Mitzel (1995) conducted an
experiment that investigated the genesis and
other aspects of chemical sensitivity. They
divided questionnaires from 112 individuals
who had previously reported a chemical sensi-
tivity into two subgroups based on the origin
of the condition. One subgroup consisted of
questionnaires from individuals who devel-
oped their sensitivity after a major exposure to
organophosphate pesticides, whereas the other
subgroup was composed of questionnaires
from people who traced their sensitivity to an
exposure to building materials. The authors
postulated that the degree of neurotoxicity
would be greater from pesticide exposure than
from an exposure to the class of chemicals
used in building materials. A comparison of
the two subgroups indicated that regardless of
exposure origin, individuals in both subgroups
experienced similar symptoms. There was,
however, a considerable difference between
the subgroups in the severity of the symptoms,
with the pesticide-origin subgroup experienc-
ing more severe symptoms than the building
material–origin subgroup. This differentiation
of symptom severity between subgroups led
the authors to conclude that chemical sensi-
tivity has speciﬁc physical dynamics inconsis-
tent with somatoform disorders. The results
of Mitzel and Miller (1995), therefore, sug-
gest that chemical sensitivity has a physiologic
genesis and is not psychogenic.
Methods
The research design of the second phase of our
study required the construction and adminis-
tration of an expanded measurement instru-
ment and the implementation of statistical
measurements to evaluate its reliability and
validity. In addition, we compared our ﬁndings
with the results of Miller and Mitzell (1995) to
evaluate the external validity of the data.
The second phase questionnaire had 71
questions and was administered only to
individuals who had previously reported a
hypersensitivity to common chemicals in the
first phase. The sample used in this second
phase was a derivative of the random survey,
thus ensuring that it was representative of the
target population. The initial phase located
199 individuals who reported a hypersensi-
tivity to chemicals. These individuals became
the pool of potential subjects for the follow-
up study in the second phase. Subjects were
called a few months after the completion of
the initial survey and asked if they would
answer a longer and more detailed question-
naire. Between the two phases, a number of
potential subjects had moved, had become
too ill to participate, or otherwise declined.
The loss of these potential subjects ultimately
reduced the size of the second phase sample
to 69—approximately one-third of the 199
persons reporting hypersensitivity.
Despite its random genesis, the sample is
too small to ensure randomness. In addition,
because the sample is small, it could not be
divided into seasonal cohorts. We evaluated
the reliability of the findings of the second
phase, however, by using statistical measures of
internal consistency. Measurements of
Cronbach’s coefﬁcient of α and other measures
of interitem correlation were used on several
clusters of related questions to determine con-
sistency levels of the responses. A subsequent
item analysis was conducted to further evaluate
the ﬁndings and promote the integrity of the
study. For the Cronbach and other interitem
analysis, questions about reaction triggers as
well types of symptoms were clustered. We
also used an additional cluster consisting of
questions about behavior modiﬁcations.
To ensure face validity, we pretested the
expanded questionnaire. The pretest uncovered
no signiﬁcant problems and the measurement
instrument was judged acceptable. External
validity was promoted by constructing the
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Table 5. Second-phase data: nature of symptoms.a
Question % (n)
What is the severity of your symptoms?
Severe 23.2 (16)
Somewhat severe 29.0 (20)
Mild 42.0 (29)
No problem 5.8 (4)
What is the length of time after exposure
that symptoms appear?
Immediately 42.0 (29)
Within an hour 24.6 (17)
Many hours or more 5.8 (4)
Different lengths of time 26.1 (18)
Don’t know 1.4 (1)
What is the duration of your symptoms?
Several hours or less 47.8 (33)
Several days 40.6 (28)
Week or more 11.6 (8)




Seldom or never 2.9 (2)
Don’t know 1.4 (1)
aUnequal totals result from rounding and/or missing data.
Table 6. Second-phase data: symptoms.a
Don’t
Yes No know
Symptom % (n)%  ( n)%  ( n)
Headache 88.4 (61) 11.6 (8) 0 (0)
Burning eyes 76.8 (53) 23.2 (16) 0 (0)
Concentration 31.9 (22) 65.2 (45) 2.9 (2)
Nausea/stomach 55.1 (38) 43.5 (30) 1.4 (1)
Muscle pain 30.4 (21) 65.2 (45) 4.3 (3)
Dizziness 46.4 (32) 52.2 (36) 1.4 (1)
Fever 17.4 (12) 82.6 (57) 0 (0)
Unconsciousness 7.2 (5) 92.8 (64) 0 (0)
Asthma 59.4 (41) 40.6 (28) 0 (0)
Other 50.7 (35) 49.3 (34) 0 (0)
aUnequal totals result from rounding and/or missing data.
Table 7. Second-phase data: reaction triggers and severity.a
No Severe Medium Mild Total yes
Question % (n)%  ( n)%  ( n)%  ( n)%  ( n)
What produces your symptoms 
and how severe are they?
Perfume 18.8 (13) 21.7 (15) 31.9 (22) 27.5 (19) 81.2 (56)
Cleaners 11.6 (8) 27.5 (19) 39.1 (27) 21.7 (15) 88.4 (61)
Fresh ink 69.6 (48) 10.1 (7) 8.7 (6) 7.2 (5) 26.1 (18)a
Appliances 87.0 (60) 2.9 (2) 4.3 (3) 2.9 (2) 10.1 (7)a
Pesticides 14.5 (10) 34.8 (24) 27.5 (19) 18.8 (13) 81.2 (56)a
Chlorine/water 55.1 (38) 7.2 (5) 15.9 (11) 15.9 (11) 39.1 (27)a
Tobacco smoke 17.4 (12) 33.3 (23) 27.5 (19) 21.7 (15) 82.6 (57)
New carpet 37.7 (26) 20.3 (14) 15.9 (11) 17.4 (12) 53.6 (37)a
Furniture 53.6 (37) 14.5 (10) 13.0 (9) 11.6 (8) 39.1 (27)a
Salon/barber 33.3 (23) 21.7 (15) 15.9 (11) 23.2 (16) 60.9 (42)a
Public parks 21.7 (15) 20.3 (14) 15.9 (11) 15.9 (11) 52.2 (36)a
Car exhaust 20.3 (14) 26.1 (18) 20.3 (14) 26.1 (18) 72.5 (50)a
What actions of others produce your 
symptoms and how severe are they?
Laundry 53.6 (37) 5.8 (4) 4.3 (3) 8.7 (6) 18.8 (13)a
Lawn pesticides 46.4 (32) 4.3 (3) 13 (9) 14.5 (10) 31.9 (22)a
Running car 60.9 (42) 4.3 (3) 2.9 (2) 7.2 (5) 14.5 (10)a
Others’ smoke 47.8 (33) 5.8 (4) 5.8 (4) 21.7 (15) 33.3 (23)a
Barbecue grill 44.9 (31) 14.5 (10) 10.1 (7) 14.5 (10) 39.1 (27)a
aUnequal totals result from “Don’t know” or refused answers and/or missing data.questionnaire to conform with recommenda-
tions made by the federal Interagency
Workgroup on Multiple Chemical Sensitivity
(1998), thus allowing comparisons with subse-
quent studies.
Findings
Severity and reaction duration of symptoms.
The ﬁrst question asked about the severity of
a subject’s sensitivity to common chemicals,
with the four response categories being
“severe,” “somewhat severe,” “mild,” and “lit-
tle problem.” There was close to an even split
between the two more intense responses
(“severe” and “somewhat severe”), with
52.2% (n = 36), and the less intense responses
(“mild” and “little problem”), with 47.8%
(n =3 4). The distribution of answers was
23.2% (n = 16) “severe,” 29% (n = 20)
“somewhat severe,” 42% (n = 29) “mild,” and
only 5.8% (n = 4) “no problem” (Table 5).
In subsequent questions, respondents
were asked about the time reactions took to
manifest. The largest group of respondents
(42%, n = 29) reported that their reactions
began almost immediately after an exposure:
“within an hour” was the answer given by
24.6% (n = 17) of the subjects, and only 5.8%
(n =4 ) said it took many hours to react.
“Different times depending on the type of
exposure” was the answer given by 26.1%
(n = 18) of the sample, and 1.4% (n = 1) did
not know. When asked questions regarding
duration of reactions and if reactions to sub-
stances that made them sick were always the
same, 47.8% (n = 33) of the respondents said
reactions lasted several hours, 40.6% (n = 28)
reported several days, and 11.6% (n = 8) said
several weeks. Additionally, 68.1% (n = 47)
replied that reactions were “always the same,”
18.8% (n = 13) said that they “usually respond
the same way,” and 8.7% (n = 6) indicated
that they “sometimes react the same way.”
Only 2.9% (n = 2) said that “they seldom or
never react in the same way,” and 1.4% (n =1 )
did not know.
Types of symptoms. Responses to questions
about the type of symptoms experienced after
an exposure to an offending substance
(Table 6) were as follows: headaches (88.4%,
n = 61), burning eyes (76.8%, n = 53), stom-
ach distress/nausea (55.1%, n = 38), dizziness
(46.4%, n = 32), loss of mental concentration
(31.9%, n = 22), and muscle pain (30.4%,
n = 21). Fever was a less common symptom
(17.4%, n = 12), and loss of consciousness
affected 7.2% (n = 5) of the people in the sur-
vey; 59.4% (n = 41) of the respondents experi-
enced asthma-like symptoms such as breathing
difﬁculty after an exposure to an irritating sub-
stance, and 50.7% (n = 35) of the respondents
indicated that they suffered from a variety of
other symptoms.
Triggering mechanisms and etiology. We
asked several questions designed to identify the
triggers that set off reactions and also to deter-
mine their magnitude (Table 7). After reading
a list of substances and products to the respon-
dents, interviewers asked which substances
made them sick and how serious their negative
reactions were. The products that made the
largest percentage of respondents sick were
cleaning agents (88.4%, n=61), pesticides
(81.2%, n=56), and perfume (81.2%,
n = 56). Car exhaust (72.5%, n=50), barber
shops/beauty salons (60.9%, n=42), new car-
pets (53.6%, n=37), new furniture (39.1%,
n = 27), chlorine in household water (39.1%,
n = 27), and fresh ink (26.1%, n = 18) were
also common triggers.
Several additional questions were asked to
determine if the product usage or behavior of
other people could act as a triggering mecha-
nism for reactions. The most frequently cited
behaviors of others that triggered reactions
were smoke from a neighbor’s fireplace,
wood stove, or barbecue grill (39.1%,
n = 27); secondhand tobacco smoke (33.3%,
n = 23); a neighbor’s use of pesticide or weed
killers (31.9%, n = 22); or use of laundry
products (18.8%, n = 13).
In this phase we also investigated the
potential origin (initiation) of hypersensitivity
(Table 8). The percentage of respondents who
reported that they were “sure” of the original
cause of their hypersensitivity made up 14.5%
(n = 10) of the sample, and an additional
26.1% (n = 18) replied that they were “pretty
sure” what caused (initiated) their symptoms.
The subjects who could identify or suspect a
probable cause of their hypersensitivity were
asked additional questions to help uncover the
etiology of MCS. The respondents reported
that their original hypersensitivity was pro-
duced by exposure to pesticides, 27.5%
(n = 19); harsh cleaners or solvents, 27.5%
(n = 19); new construction (building materi-
als), 17.4% (n = 12); and gasoline or other
petroleum products, 15.9% (n =1 1).
A cross-tabulation of cause (initiation) of
symptoms with severity of symptoms indi-
cates that respondents who could identify the
cause of their symptoms were more likely to
report that they were severe (50%, n =5 )
than those who did not know the cause
(16%, n = 6) (Table 9).
Linkage to other medical conditions.
Several studies speculated that MCS is either
a product of or connected to other disorders.
The questionnaire, therefore, inquired about
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Table 8. Second-phase data: etiology.
Refused
Yes No Maybe or missing
Question % (n)%  ( n)%  ( n)%  ( n)
Do you know what originally caused your symptoms? 14.5 (10) 55.1 (38) 26.1 (18) 4.3 (3)
Do you know or suspect the following as the original cause?a
Pesticides 27.5 (19) 34.8 (24) 33.3 (23) 4.3 (3)
Solvents 27.5 (19) 30.4 (21) 37.7 (26) 4.3 (3)
Building materials 17.4 (12) 43.5 (30) 34.8 (24) 4.3 (3)
Petroleum products 15.9 (11) 43.5 (30) 36.2 (25) 4.3 (3)
aMultiple answers possible.
Table 9. Cross-tabulations of second-phase data: cause (initiation) of sensitivity with symptom severity.
Degree of symptomsa
Somewhat No
Severe severe Mild problem Total
Cause % (n)%  ( n)%  ( n)%  ( n) n
Known
Yes 50 (5) 20 (2) 20 (2) 10 (1) 10
No 16 (6) 32 (12) 45 (17) 8 (3) 38
Maybe 22 (4) 28 (5) 50 (9) 0 18
Refused/missing – – – – 2
Pesticide
Yes 37 (7) 32 (6) 21 (4) 11 (2) 19
No 25 (6) 21 (5) 46 (11) 8 (2) 24
Don’t know 13 (3) 30 (7) 57 (13) 0 23
Refused/missing – – – – 2
New construction
Yes 33 (4) 33 (4) 25 (3) 8 (1) 12
No 20 (6) 30 (9) 47 (14) 3 (1) 30
Don’t know 25 (6) 25 (6) 50 (12) 0 24
Refused/missing – – – – 3
Petroleum products
Yes 46 (5) 36 (4) 18 (2) 0 11
No 17 (5) 30 (9) 47 (14) 7 (2) 30
Don’t know 24 (6) 24 (6) 52 (13) 0 25
Refused/missing – – – – 3
aUnequal totals result from rounding and/or missing data.other medical problems (Table 10). Subjects
were ﬁrst asked if they had any medical con-
ditions in addition to their sensitivity to
chemicals, and those who answered “yes”
were asked if they suffered from any of the
following conditions: gastrointestinal prob-
lems, fibromyalgia, chronic fatigue, or any
other condition. All subjects were then asked
about their allergies to natural substances such
as pollen, animal hair, dust/dust mites, molds,
and other natural allergens.
A majority of the respondents (53.6%,
n = 37) replied that they had another medical
condition that could be related to their hyper-
sensitivity, and an additional 7.2% (n =5 )
were not sure. Gastrointestinal problems were
experienced by 26.1% (n = 18) of the subjects,
and 21.7% (n = 15) said they have ﬁbromyal-
gia. In addition, 18.8% (n = 13) indicated that
they suffer from chronic fatigue or other
immunologic troubles, and 27.5% (n = 19)
answered that they have another related med-
ical condition. The cumulative response of the
subjects to all of the related conditions was
> 54.4% because several gave more than one
positive answer.
A larger percentage (73.9%, n =5 1) indi-
cated that they had allergies to natural sub-
stances. Pollen was an irritant for 65.2%
(n = 45) of the subjects, 52.2% (n = 36)
reported an allergy to animal hair or dander,
55.1% (n = 38) had an allergy to dust or dust
mites, and 49.3% (n = 34) reacted to molds.
Moreover, 44.9% (n = 31) said they were
allergic to other natural allergens. Again, the
cumulative numbers exceeded the total num-
ber of subjects with a positive reply to allergies
because of multiple responses.
Linkage to mental illness. We asked ques-
tions related to mental illness because of the
contention by some researchers that MCS is
psychogenic (Gots 1995). The questions,
however, were constructed to investigate if
mental problems preceded or followed the
development of symptoms (Table 11).
Only 1.4% (n = 1) of the respondents
reported experiencing depression, anxiety, or
other emotional problems before the onset of
their symptoms. An additional 5.8% (n =4 )
replied that they did not know if they had
these emotional symptoms or not before they
developed their hypersensitivity. Only 4.3%
(n = 3) of the respondents had ever taken any
medication for emotional problems before the
onset of their chemical hypersensitivity symp-
toms. In contrast, 37.7% (n = 26) of the
respondents said that they experienced
depression, anxiety, or other emotional prob-
lems after they developed their hypersensitiv-
ity, and 27.5% (n = 19) had taken some
medication for these emotional problems after
the emergence of their condition.
Lifestyle modifications. The necessity of
avoiding offending substances can force a
hypersensitive person to make numerous
lifestyle changes; thus, several questions were
asked to determine the extent of these alter-
ations. Subjects were asked if they had to
change their residence or alter their home,
and if so, in what manner (Table 12). Of the
respondents, 13% (n = 9) moved from their
homes because of their hypersensitivity. A
much larger percentage made major adjust-
ments to their living environment; 34.8%
(n = 24) reported that they removed carpeting
or furniture from their home, and 47.8%
(n = 33) stated that they had installed air
and/or water ﬁltration systems. About three-
fourths of the respondents (76.8%, n = 53)
said they had changed their cleaning and per-
sonal hygiene supplies, and 15.9% (n = 11)
said they had switched from gas appliances to
electric appliances. An additional 33.3%
(n = 23) reported making other changes to
their residences.
Demographics. The ﬁnal questions asked
about the race/ethnicity, family income, mari-
tal status, age, and sex of the respondents
(Table 13). Whites made up 66.7% (n = 46)
of individuals with a hypersensitivity, blacks
comprised 27.5% (n = 19), and Hispanics
were 2.9% (n = 2) of this group. An addi-
tional 2.9% (n = 2) replied “other” or refused
to identify their race or ethnicity.
The annual household incomes of people
with a hypersensitivity were evenly spread over
the various levels, with 11.6% (n = 8) reporting
an income of > $100,000; 23.2% (n = 16) with
an income level of $50,000–$100,000; 26.1%
(n = 18) with $20,000–50,000; and 27.5%
(n = 19) reporting an income < $20,000.
Regarding marital status, 52.2% (n = 36)
of the individuals in the sample were married
or living as a couple, 13% (n = 9) were
divorced or separated, 14.5% (n = 10) were
widowed, and 18.8% (n = 13) had never been
married. An additional 1.4% (n = 1) refused
to specify their marital status. The age range of
the sample was reasonably well distributed
with a minor bias toward upper age groups,
with 33.3% (n = 23) of the subjects ≥ 60 years
of age, 39.1% (n = 27) 40–59 years of age,
23.2% (n = 16) 20–39 years of age, and only
4.3% (n = 3) < 20 years of age. The sample
was 79.7% (n = 55) female and 18.8%
(n = 13) male, with some data missing.
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Table 11. Second-phase data: emotional problems and/or use of medication (e.g., for depression or anxiety).a
Yes No Don’t know Refused/missing
Question % (n)%  ( n)%  ( n)%  ( n)
Trouble before symptoms appeared 1.4 (1) 92.8 (64) 5.8 (4) 0.0 (0)
Trouble after symptoms appeared 37.7 (26) 62.3 (43) 0.0 (0) 0.0 (0)
Medication used before symptoms appeared 4.3 (3) 94.2 (65) 1.4 (1) 0.0 (0)
Medication used after symptoms appeared 27.5 (19) 72.5 (50) 0.0 (0) 0.0 (0)
aUnequal totals result from rounding and/or missing data.
Table 12. Second-phase data: changes in the home since symptoms appeared.a
Changes since Yes No Refused/missing
symptoms appeared % (n)%  ( n)%  ( n)
Carpet/furniture 34.8 (24) 65.2 (45) 0 (0)
Water/air ﬁltration 47.8 (33) 50.7 (35) 1.4 (1)
Cleaning/hygiene supplies 76.8 (53) 23.2 (16) 0 (0)
Gas appliances 15.9 (11) 84.1 (58) 0 (0)
Other changes 33.3 (23) 65.2 (45) 1.4 (1)
House/apt. (moved) 13.0 (9) 85.5 (59) 1.4 (1)
aUnequal totals result from rounding and/or missing data.
Table 10. Second-phase data: related medical problems.
Don’t Refused/
Yes No know missing
Question % (n)%  ( n)%  ( n)%  ( n)
Do you have any other related medical problems? 53.6 (37) 37.7 (26) 7.2 (5) 1.4 (1)
Do you have any of the following medical problems?a
Gastrointestinal/stomach 26.1 (18) 63.8 (44) 2.9 (2) 7.2 (5)
Fibromyalgia 21.7 (15) 69.6 (48) 1.4 (1) 7.2 (5)
Chronic fatigue 18.8 (13) 72.5 (50) 1.4 (1) 7.2 (5)
Other 27.5 (19) 60.9 (42) 4.3 (3) 7.2 (5)
Do you have any allergies to natural substances; if so, to what?a
Total 73.9 (51) 23.2 (16) 2.9 (2) 0 (0)
Pollen 65.2 (45) 24.6 (17) 4.3 (3) 5.7 (4)
Animal hair/dander 52.2 (36) 37.7 (26) 2.9 (2) 7.1 (5)
Dust/dust mites 55.1 (38) 33.3 (23) 5.8 (4) 5.7 (4)
Molds 49.3 (34) 40.6 (28) 4.3 (3) 5.7 (4)
Other 44.9 (31) 43.5 (30) 5.8 (4) 5.7 (4)
aMultiple answers possible.Discussion: Second-Phase Findings
The Cronbach’s α coefficients for the three
clusters of variables indicate differing degrees of
internal consistency between similar questions.
The highest α coefﬁcient (0.7028) was for the
cluster of questions on triggers, with the cluster
dealing with behavior modiﬁcations having a
coefficient of 0.6882. The α for questions
about symptoms was the lowest at 0.5054.
(Supplemental information is available at
http://ehpnet1.niehs.nih.gov/members/
2003/5940/supplemental.pdf). All of these
indicate at least a moderate amount of internal
consistency. Our analysis suggests that individ-
uals with a hypersensitivity displayed greater
consistency in what triggered a reaction than in
the type of symptoms they experienced after an
exposure. A subsequent item analysis revealed
that the trigger cluster coefﬁcient was signiﬁ-
cantly inﬂuenced by the inclusion of electrical
appliances; when this potential trigger was
removed from the analysis, the internal consis-
tency of the trigger cluster was greater. The
item analysis also suggested that these ﬁndings
have more relevance to MCS as a condition
than to the appropriateness of the measure-
ment instrument. Because the questions used
in this phase were derived from numerous
anecdotal studies of the symptoms, triggers,
and behavior of MCS sufferers, the α coefﬁ-
cients indicated that individuals with MCS
exhibit a variety of symptomologies and behav-
ior adjustments. The analysis also suggested
that not all individuals with a hypersensitivity
react in the same manner when exposed to a
triggering substance and that these individuals
can take different actions to accommodate
their hypersensitivity.
We generated cross-tabulations of data in
the second phase of this study to evaluate the
external validity of the data in relationship
with Miller and Mitzel’s ﬁndings (Miller and
Mitzel 1995). Although data on etiology,
symptomatology, and severity were cross-tabu-
lated with symptom severity, it is important to
note that the method of data-gathering in this
study differs considerably from Miller and
Mitzel’s methods. Their entire sample con-
sisted of respondents who could definitively
identify the origin (initiation) of their sensitiv-
ity, whereas 55.9% (n = 38) of the 69 subjects
in our study could not identify what originally
initiated their sensitivity. Only 14.7% (n = 10)
of the subjects in our study reported knowing
with certainty what caused their sensitivity,
with an additional 26.5% (n = 18) having
some idea. Consequently, the number of
applicable cases in this study is limited and
impedes any analytical comparison with
Miller and Mitzel’s ﬁndings.
The most significant cross-tabulation is
between the severity of symptoms and subjects
who either knew or did not know the origin of
their sensitivity. Individuals who could iden-
tify the origin of their sensitivity were far more
likely to report severe symptoms than people
who did not know the original cause. Of the
10 respondents who could identify the origin,
50% (n = 5) described their symptoms as
severe. Only 16% (n = 6) of the 38 respon-
dents who did not know the cause say severe,
with 22% (n = 4) of the 18 respondents who
suspected a cause reporting severe symptoms.
These results provide some substantiation for
Miller and Mitzel’s data (Miller and Mitzel
1995). The number of cases on the other
cross-tabulations of severity with pesticide eti-
ology, petroleum products etiology, and build-
ing material etiology is too limited, however,
for a meaningful analysis. The ﬁndings of this
phase indicate that for a substantial number of
the respondents, their hypersensitivity is dis-
ruptive and life-altering, and a majority experi-
ence symptoms described as being either
severe or somewhat severe.
Very few of the respondents (1.4%) had a
history of mental or emotional problems prior
to the onset of their hypersensitivity, even
though over one-third (37.7%) experienced
some emotional troubles after their hypersensi-
tivity manifested. These results are relevant to
the question of etiology and tend to support
Miller and Mitzel’s conclusion (Miller and
Mitzel 1995) that MCS is inconsistent with
somatoform disorders. The difference between
the presymptom and postsymptom findings
weakens the notion that MCS is psychogenic,
or that a chemical hypersensitivity is a product
of emotional disturbance. These ﬁndings indi-
cate, in contrast, that the physical problems
emerge ﬁrst and emotional problems develop
only afterward. It is plausible that hypersensi-
tivity could be so disruptive that it produces
substantial mental stress as the individuals
attempt to cope with the limitations it pro-
duces. Another explanation may be that expo-
sures to toxic agents can affect brain functions
related to mood and emotions (Bell et al.
1997). This is an area that needs considerably
more research (Ashford 1999).
The demographic characteristics of indi-
viduals with hypersensitivity tend to reflect
those of the general population in the area.
The distribution of whites, blacks, and
Hispanics in the sample approximates their
proportions of the population in the Atlanta
metropolitan area. Hypersensitivity also is
widely distributed among education and
income levels, even though it is more com-
mon in females. These ﬁndings tend to con-
ﬁrm the CDHS investigation (Kreutzer et al.
1999), which also found that hypersensitivity
cuts across race/ethnicity, education, and
income groupings. This study, therefore, con-
tributes to the increasing evidence that MCS
is widespread and serious and deserving of
substantially more research.
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